Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-11

Clinical Trial Update: Pain Reduction Caused by the Combined Treatment of Physiotherapy, Oral Gabapentin and Oral Ibuprofen Arginine. [Phase 4]

View source ↗

Summary

Phase 4 trial completed evaluating pain reduction in carpal tunnel syndrome using a combination of physiotherapy, gabapentin, and ibuprofen arginine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)
  • ibuprofen arginine (ibuprofen arginine)

Snippet

Sponsor: Universidad Europea de Madrid | Conditions: Carpal Tunnel Syndrome | Phase 4 | Status: COMPLETED